The decisive midterm elections will have significant implications for a wide range of health policy priorities—in Congress, ...
The answer lies in a powerful narrative circulating for years before the FDA convened its panel, one that recast the original ...
Advocates for Head Start are faced with the question of whether the program can remain as effective without the same ...
Nearly two-thirds of respondents in a Cornell Health Policy Insight Panel survey said HR 1 implementation could cause states to scale back Medicaid expansions; a majority said the law’s limits on ...
Opinion
Expanding GLP-1 Access Under The BALANCE Model: Supporting Sustainable Medicaid Participation
Despite lower negotiated prices, uncertainty around GLP-1 uptake, budget exposure, and long-term cost offsets may limit state participation in BALANCE.
Rachel Sachs breaks down a final rule from CMS establishing the framework for the Medicare Drug Price Negotiation Program in 2029 and evaluates how the Trump administration's broader drug pricing ...
MedPAC’s work is guided by the principles of supporting beneficiary access to high-quality care, creating incentives for providers and plans to operate efficiently, and promoting value for ...
Together, these trends show fewer opioid prescriptions dispensed, less opioid dosage exposure, fewer patients exposed to prescription opioids, and more patients receiving medications used for ...
Hospice care accounts for an increasing share of Medicare spending, paid by Medicare through a daily capitated rate that is not risk-adjusted. In recent years, for-profit entities, notably private ...
In the past year, the Innovation Center has built the foundation of its evidence-based prevention pillar. The Center intends to maintain momentum with new prevention-focused payment models to advance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results